The company is also planning to launch first set of biosimilars and vaccines in growth markets during this time, Aurobindo Pharma said in an investor presentation
from Latest News https://ift.tt/2DKg84V
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Aurobindo Pharma to launch oncology, respiratory products in US by 2021
0 comments: